SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-19-045755
Filing Date
2019-12-11
Accepted
2019-12-11 16:54:50
Documents
6
Period of Report
2019-12-11
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K alec-8k_20191211.htm 8-K 31214
2 EX-99.1 alec-ex991_6.htm EX-99.1 33203
3 EX-99.2 alec-ex992_7.htm EX-99.2 14199
4 GRAPHIC ggmolt4xy1qj000001.jpg GRAPHIC 16932
5 GRAPHIC ggmolt4xy1qj000006.jpg GRAPHIC 15462
6 GRAPHIC gcvpvic05ia2000001.jpg GRAPHIC 57221
  Complete submission text file 0001564590-19-045755.txt   203831
Mailing Address 151 OYSTER POINT BLVD., SUITE 300 SOUTH SAN FRANCISCO CA 94080
Business Address 151 OYSTER POINT BLVD., SUITE 300 SOUTH SAN FRANCISCO CA 94080 415-231-5660
Alector, Inc. (Filer) CIK: 0001653087 (see all company filings)

IRS No.: 462702363 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38792 | Film No.: 191280249
SIC: 2836 Biological Products, (No Diagnostic Substances)